News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
40 Under 40
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
40 Under 40
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
753,046 Results
Type
Article (52691)
Company Profile (336)
Press Release (700019)
Multimedia
Podcasts (80)
Webinars (13)
Section
Business (216665)
Career Advice (2168)
Deals (37071)
Drug Delivery (109)
Drug Development (84355)
Employer Resources (177)
FDA (17164)
Job Trends (15974)
News (365366)
Policy (35128)
Tag
Academia (2858)
Accelerated approval (5)
Adcomms (23)
Allergies (91)
Alliances (53515)
ALS (94)
Alzheimer's disease (1451)
Antibody-drug conjugate (ADC) (139)
Approvals (17165)
Artificial intelligence (288)
Autoimmune disease (23)
Automation (16)
Bankruptcy (375)
Best Places to Work (12252)
BIOSECURE Act (19)
Biosimilars (107)
Biotechnology (237)
Bladder cancer (82)
Brain cancer (28)
Breast cancer (291)
Cancer (2337)
Cardiovascular disease (187)
Career advice (1823)
Career pathing (32)
CAR-T (161)
Cell therapy (445)
Cervical cancer (21)
Clinical research (68340)
Collaboration (879)
Company closure (1)
Compensation (542)
Complete response letters (21)
COVID-19 (2764)
CRISPR (46)
C-suite (258)
Cystic fibrosis (105)
Data (2244)
Decentralized trials (2)
Denatured (34)
Depression (50)
Diabetes (277)
Diagnostics (6728)
Digital health (19)
Diversity (9)
Diversity, equity & inclusion (45)
Drug discovery (126)
Drug pricing (109)
Drug shortages (30)
Duchenne muscular dystrophy (95)
Earnings (89655)
Editorial (40)
Employer branding (22)
Employer resources (152)
Events (120048)
Executive appointments (754)
FDA (18478)
Fibrodysplasia Ossificans Progressiva (1)
Friedreich's ataxia (4)
Frontotemporal dementia (8)
Funding (789)
Gene editing (114)
Generative AI (27)
Gene therapy (322)
GLP-1 (779)
Government (4737)
Grass and pollen (5)
Guidances (67)
Healthcare (20149)
Huntington's disease (23)
IgA nephropathy (27)
Immunology and inflammation (120)
Indications (30)
Infectious disease (2913)
Inflammatory bowel disease (144)
Inflation Reduction Act (8)
Influenza (53)
Intellectual property (100)
Interviews (328)
IPO (17056)
IRA (42)
Job creations (4159)
Job search strategy (1555)
Kidney cancer (10)
Labor market (38)
Layoffs (497)
Leadership (19)
Legal (8591)
Liver cancer (79)
Lung cancer (331)
Lymphoma (157)
Machine learning (7)
Management (62)
Manufacturing (319)
MASH (70)
Medical device (14489)
Medtech (14494)
Mergers & acquisitions (20571)
Metabolic disorders (729)
Multiple sclerosis (82)
NASH (16)
Neurodegenerative disease (100)
Neuropsychiatric disorders (31)
Neuroscience (2016)
NextGen: Class of 2025 (7080)
Non-profit (4810)
Now hiring (39)
Obesity (390)
Opinion (229)
Ovarian cancer (76)
Pain (92)
Pancreatic cancer (85)
Parkinson's disease (154)
Partnered (21)
Patents (244)
Patient recruitment (114)
Peanut (50)
People (61314)
Pharmaceutical (73)
Pharmacy benefit managers (19)
Phase I (21360)
Phase II (30009)
Phase III (22377)
Pipeline (1218)
Policy (144)
Postmarket research (2755)
Preclinical (9210)
Press Release (71)
Prostate cancer (109)
Psychedelics (32)
Radiopharmaceuticals (266)
Rare diseases (396)
Real estate (6495)
Recruiting (65)
Regulatory (23970)
Reports (46)
Research institute (2550)
Resumes & cover letters (371)
Rett syndrome (5)
RNA editing (5)
RSV (45)
Schizophrenia (76)
Series A (137)
Series B (87)
Service/supplier (16)
Sickle cell disease (54)
Special edition (14)
Spinal muscular atrophy (153)
Sponsored (32)
Startups (3968)
State (2)
Stomach cancer (14)
Supply chain (72)
Tariffs (40)
The Weekly (44)
Vaccines (749)
Venture capitalists (42)
Weight loss (268)
Women's health (38)
Worklife (16)
Date
Last 7 days (919)
Last 30 days (2563)
Last 365 days (33863)
2025 (11163)
2024 (36649)
2023 (41666)
2022 (53018)
2021 (57739)
2020 (56595)
2019 (49655)
2018 (37584)
2017 (34495)
2016 (34457)
2015 (40574)
2014 (34256)
2013 (29541)
2012 (31878)
2011 (32510)
2010 (30890)
Location
Africa (819)
Alabama (54)
Alaska (7)
Arizona (249)
Arkansas (14)
Asia (42465)
Australia (7112)
California (6285)
Canada (2043)
China (548)
Colorado (278)
Connecticut (293)
Delaware (156)
Europe (93485)
Florida (925)
Georgia (217)
Idaho (62)
Illinois (587)
India (26)
Indiana (320)
Iowa (11)
Japan (167)
Kansas (109)
Kentucky (26)
Louisiana (11)
Maine (62)
Maryland (939)
Massachusetts (4755)
Michigan (243)
Minnesota (409)
Mississippi (2)
Missouri (89)
Montana (30)
Nebraska (25)
Nevada (65)
New Hampshire (69)
New Jersey (1771)
New Mexico (29)
New York (1786)
North Carolina (1053)
North Dakota (9)
Northern California (2726)
Ohio (209)
Oklahoma (15)
Oregon (37)
Pennsylvania (1403)
Puerto Rico (13)
Rhode Island (35)
South America (1223)
South Carolina (24)
South Dakota (1)
Southern California (2354)
Tennessee (103)
Texas (929)
United States (23985)
Utah (189)
Virginia (152)
Washington D.C. (66)
Washington State (584)
West Virginia (3)
Wisconsin (58)
753,046 Results for "otonexus medical technologies inc".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
BioForest
OtoNexus Medical Technologies Accepted into Prestigious Pediatric Medical Device Accelerator, CTIP
OtoNexus Medical Technologies Inc., is proud to announce its recent acceptance into The Consortium for Technology & Innovation in Pediatrics (CTIP).
December 12, 2023
·
2 min read
BioForest
OtoNexus Medical Technologies Selected for Elite FDA STeP Program
OtoNexus Medical Technologies is excited to announce its recent selection into U. S. Food and Drug Administration Safter Technologies Program (STeP).
December 6, 2023
·
2 min read
Business
OtoNexus Medical Technologies Welcomes Chris Rivera to its Board of Directors
OtoNexus Medical Technologies, Inc. is pleased to announce the appointment of Chris Rivera to its Board of Directors.
April 4, 2023
·
2 min read
BioForest
OtoNexus Medical Technologies Honored as a Top 100 Best Place to Work in Washington State
OtoNexus Medical Technologies, a medical device innovator, is celebrating its recognition as one of Washington’s 100 Best Workplaces.
June 28, 2023
·
2 min read
Press Releases
Autonomix Medical, Inc. Granted New European Patent for Proprietary Catheter-Based Technology
April 16, 2025
·
4 min read
Press Releases
Helius Medical Technologies, Inc. Announces the Establishment of a Wholly Owned Brain Computer Interface (“BCI”) Technology Private Subsidiary
March 13, 2025
·
5 min read
Press Releases
Autonomix Medical, Inc. Technology and Early Proof-of-Concept Study Results to be Featured in Poster Presentation at the World-Leading Course in Interventional Cardiovascular Medicine, EuroPCR
April 24, 2025
·
2 min read
Press Releases
Acuitive Technologies, Inc. Appoints Dr. Wayne Berberian as Chief Medical Officer
January 27, 2025
·
2 min read
Press Releases
Autonomix Medical, Inc. to Highlight Technology and Early Proof-of-Concept Study Results in a Poster Presentation at the 2025 European Conference on Interventional Oncology (ECIO)
April 3, 2025
·
2 min read
Press Releases
Helius Medical Technologies, Inc. Announces First Reimbursement by A Major Healthcare Provider for its Portable Neuromodulation Stimulator (PoNS®) Device
March 11, 2025
·
5 min read
1 of 75,305
Next
